Parvovirus B19 infection in kidney transplant recipients: A prospective study in a teaching hospital in Shanghai, China.
Transpl Immunol
; 74: 101667, 2022 10.
Article
em En
| MEDLINE
| ID: mdl-35835294
ABSTRACT
BACKGROUND:
There is a lack of epidemiological studies on the course and clinical characteristics of Parvovirus B19 (B19V) infections in kidney transplant (KT) recipients. This study was undertaken to provide recommendations for clinical B19V infection diagnosis and treatment.METHODS:
Serum samples of KT recipients were regularly collected and tested for B19V-DNA copies, B19V-IgG/IgM levels, as well as hematological parameters and functions of kidney and liver. The course of B19V infection was described according to the results of serology and DNA testing, and the clinical and epidemiological data were combined for analysis.RESULTS:
75% B19V infections occurred within 2 weeks after KT(n = 9). The infection rate of B19V in KT recipients was high, namely 10.17% (n = 12). The number of 10 patients IgM antibodies against B19V (IgM+) and theDNA B19V (DNA+), whereas 2 patients were IgM negative (IgM-) but DNA+. The B19V infected KT patients showed several symptoms, including anemia (100%), reduction of platelets (8.33%), and damage to liver (75%) and kidney function (16.67%) Patients with progressive anemia in the first two weeks after KT, which combined with the decrease of reticulocytes, are more likely to have B19V infection. Associations of four main therapeutic risk factors for B19V infections in KT patients have been analyzed. B19V infection was associated with use of basiliximab (OR = 1.19; 95%- CI 1.08-1.32; P = 0.003) and use of thymoglobulins (OR = 0.84; 95%-CI 0.76-0.93; P = 0.003).CONCLUSIONS:
Doctors should be alert to B19V infection, especially in the immunodeficient patients within the first two weeks after transplantation.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Transplante de Rim
/
Parvovirus B19 Humano
/
Eritema Infeccioso
/
Infecções por Parvoviridae
/
Anemia
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article